CRINETICS PHARMACEUTICALS IN (CRNX) Institutional Ownership and Insiders Activity
CRINETICS PHARMACEUTICALS IN (CRNX) is widely held by institutional investors, with 248 firms reporting positions valued at approximately $4.28B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Fmr Llc is the largest disclosed holder, reporting approximately $592.74M in CRNX holdings in its latest filing.
Recent insider activity includes 34 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
248
Total Reported Value
$4.28B
Largest Holder
Fmr Llc
Largest Position
$592.74M
Insider Transactions (90d)
34
Latest Filing Quarter
Q2 2026
New Institutional Positions
227
Funds Exiting Positions
2
Top Institutional Owners
View allInvestorReported Balance
- Fmr Llc$592.74M
- Blackrock, Inc.$365.18M
- Wellington Management Group Llp$266.85M
- Driehaus Capital Management Llc$241.87M
- Price T Rowe Associates Inc$232.48M
CRNX News
All news- Driehaus Capital Management Q2 Portfolio Shifts Focus on Technology & Healthcare
Aug 17, 2026 · valut.ai
Related CRNX Institutional Insights:
- CRNX 13F Institutional Holders
- CRNX Superinvestors
- CRNX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CRNX Insider Trading & SEC Form 4 Activity
- CRNX Articles
- Top Institutional Investor Stock Rankings